2019 annual financial data
Immunovant 2019 Operating margin
Immunovant 2019 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -450 USD and net income was -450 USD.
Operating cash flow was -28,547,000 USD.
Get free Immunovant email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -450 USD
- Net income
- -450 USD
- Operating cash flow
- -28,547,000 USD